What We're Reading: Page 27
Industry reads hand-picked by our editors
Dec 05, 2024
-
Nature
Science could solve some of the world’s biggest problems. Why aren’t governments using it?
-
Science
Unusual genetic results in prenatal tests can also flag cancers—in the mom
-
Bloomberg
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
-
NPR
Inside RFK Jr.’s nonprofit’s legal battles over vaccines and public health
Dec 04, 2024
Dec 03, 2024
Dec 02, 2024
-
NBC News
Trump’s former FDA commissioner: ‘It will cost lives in this country’ if RFK Jr. follows through on intentions
-
The Wall Street Journal
A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them?
-
The New York Times
Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Target
-
Nature News
What’s the secret to living to 100? Centenarian stem cells could offer clues
Nov 27, 2024
Nov 26, 2024
-
The Washington Post
Jim O’Neill, Silicon Valley investor, favored for HHS deputy secretary
-
Healthcare Dive
Sanofi joins J&J, Eli Lilly in proposing 340B rebate model
-
Fierce Pharma
BMS cuts 195 jobs, bringing head count subtraction to 1,329 in New Jersey
Nov 25, 2024
-
The Wall Street Journal
A 12-Year-Old’s Journey Into the World of Ozempic
-
Minnesota Star Tribune
Opaque drug discount program delivered $630 million last year to safety net hospitals, clinics in MN
-
FirstWord Pharma
AstraZeneca’s AKT inhibitor Truqap hits main goal of prostate cancer study
-
Axios
Trump’s FDA and CDC nominees signal RFK’s takeover of health agencies
Previous
